Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Grignani

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Journal for Immunotherapy of Cancer|June 14, 2022
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panelFrancesca Spada, Paolo Bossi, Corrado Caracò, et al.
Acta Oncologica (Stockholm, Sweden)|July 21, 2017
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study<sup></sup>Hans Gelderblom, Ian R Judson, Charlotte Benson, et al.
Cells|November 27, 2021
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and ChondrosarcomaGiorgia Giordano, Alessandra Merlini, Giulio Ferrero, et al.
Frontiers in Oncology|May 12, 2020
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GISTAnnalisa Astolfi, Valentina Indio, Margherita Nannini, et al.
Pediatric Blood & Cancer|June 15, 2017
Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma GroupRoberto Luksch, Giovanni Grignani, Paolo D'Angelo, et al.
Molecular Medicine (Cambridge, Mass.)|August 15, 2017
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer CellsGiulia Mesiano, Roberta Zini, Giulia Montagner, et al.
Sarcoma|March 29, 2016
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced AngiosarcomaGaetano Apice, Antonio Pizzolorusso, Massimo Di Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2017
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus DacarbazineGeorge D Demetri, Patrick Schöffski, Giovanni Grignani, et al.
Cancer Immunology, Immunotherapy : CII|May 8, 2020
Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of boneJasna Metovic, Laura Annaratone, Alessandra Linari, et al.
Cardiovascular and Interventional Radiology|February 10, 2011
Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patientsGiovanni Carlo Anselmetti, Antonio Manca, Filippo Montemurro, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Journal for Immunotherapy of Cancer|June 14, 2022
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panelFrancesca Spada, Paolo Bossi, Corrado Caracò, et al.
Acta Oncologica (Stockholm, Sweden)|July 21, 2017
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study<sup></sup>Hans Gelderblom, Ian R Judson, Charlotte Benson, et al.
Cells|November 27, 2021
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and ChondrosarcomaGiorgia Giordano, Alessandra Merlini, Giulio Ferrero, et al.
Frontiers in Oncology|May 12, 2020
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GISTAnnalisa Astolfi, Valentina Indio, Margherita Nannini, et al.
Pediatric Blood & Cancer|June 15, 2017
Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma GroupRoberto Luksch, Giovanni Grignani, Paolo D'Angelo, et al.
Molecular Medicine (Cambridge, Mass.)|August 15, 2017
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer CellsGiulia Mesiano, Roberta Zini, Giulia Montagner, et al.
Sarcoma|March 29, 2016
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced AngiosarcomaGaetano Apice, Antonio Pizzolorusso, Massimo Di Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2017
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus DacarbazineGeorge D Demetri, Patrick Schöffski, Giovanni Grignani, et al.
Cancer Immunology, Immunotherapy : CII|May 8, 2020
Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of boneJasna Metovic, Laura Annaratone, Alessandra Linari, et al.
Cardiovascular and Interventional Radiology|February 10, 2011
Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patientsGiovanni Carlo Anselmetti, Antonio Manca, Filippo Montemurro, et al.
Pageof 15